The Use of a Silver Containing Dressing (Acticoat) on Wound Complication Rates Post Elective Cesarean Section
1 other identifier
interventional
100
1 country
1
Brief Summary
The purpose of this study is to determine the effect of a silver containing dressing (Acticoat Post-Op) compared to a standard dressing (OpSite PostOp) on post elective cesarean section wound complications in obese women (BMI \>35).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started May 2011
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2011
CompletedFirst Submitted
Initial submission to the registry
November 7, 2014
CompletedFirst Posted
Study publicly available on registry
November 11, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2016
CompletedOctober 13, 2016
April 1, 2016
5.4 years
November 7, 2014
October 12, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Wound complication
Composite of: wound infection treated with antibiotics, incision and drainage, wound requiring packing, or patient requiring medical attention for concerns about wound healing.
6 weeks post-op
Study Arms (2)
Silver containing dressing
ACTIVE COMPARATORSubjects will have a silver containing dressing (Acticoat PostOp) applied at the time of elective cesarean section.
Standard dressing
PLACEBO COMPARATORSubjects will have a standard dressing (OpSite PostOp) applied at the time of elective cesarean section.
Interventions
Eligibility Criteria
You may qualify if:
- Women scheduled for elective cesarean section
- BMI \>35 at the pre-op visit
- consent to participate
You may not qualify if:
- allergy to silver
- immunocompromised (HIV/AIDS, on immunosuppressive medications)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Regina General Hospital
Regina, Saskatchewan, S4P 0W5, Canada
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 7, 2014
First Posted
November 11, 2014
Study Start
May 1, 2011
Primary Completion
October 1, 2016
Study Completion
October 1, 2016
Last Updated
October 13, 2016
Record last verified: 2016-04